Pharmaceutical Company Funding and its Consequences: A Qualitative Systematic Review
Contemporary Clinical Trials, Vol. 29, pp. 109-113, 2008
6 Pages Posted: 12 Jun 2008
Date Written: 2008
Abstract
This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.
Keywords: industry funding, sponsorship, pharmaceutical companies, clinical trials, bias
Suggested Citation: Suggested Citation
Sismondo, Sergio, Pharmaceutical Company Funding and its Consequences: A Qualitative Systematic Review (2008). Contemporary Clinical Trials, Vol. 29, pp. 109-113, 2008, Available at SSRN: https://ssrn.com/abstract=1143764
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.